Please note: This event has been postponed until September 10th

“Trauma is not what happens to us, but what we hold inside in the absence of an empathetic witness” -Peter Levine I

n this era of trauma informed care and psychedelic healing, the trinity of mindfulness, somatic embodiment, and psychedelic journeys serve as three powerful and often essential pillars for healing.

In this fireside chat, Salimeh Tabrizi, founding member of the PAC, plant medicine facilitator and clinical counselor and David Field, somatic experiencing and trauma integration therapist discuss and explore the ways in which somatic experiencing and psychedelic-assisted therapy work, as well as near death experiences, together help individuals and couples access deeper healing, connection and resilience; the kind that is embodied and fully felt in the body and spirit as well as the mind.

Join us for an honest, grounded conversation about somatic experiencing, trauma integration healing and specific practices for individuals, couples and communities.

The webinar includes a structured Q&A session, at the end, to deepen the discussion.

Please note the early start time of 10:00am PT/1:00pm ET

*Please note this is a live event in Vancouver, BC

Something shifted in Ottawa this week.

On June 16th, Conservative MP Corey Tochor introduced Bill C-286 — Thomas's Law — legislation that would allow Canadian physicians to prescribe psilocybin directly to patients, bypassing the federal approval process that has left thousands of people without access to a treatment that research shows can be life-changing.

The bill bears the name of Thomas Hartle — a Saskatchewan father who, in 2020, became the first Canadian to receive a legal psilocybin exemption while battling stage IV colon cancer. When his cancer progressed, his renewal requests sat unanswered for months. A dying man spent his final years fighting bureaucratic silence just to keep a treatment that was helping him. Thomas passed away in 2024. This bill is his legacy.

Since January 2022, Health Canada has issued only 354 psilocybin authorizations through the Special Access Program — with approval rates now sitting at roughly 30%. For patients living with PTSD, treatment-resistant depression, addiction, and end-of-life distress, that's not a safety net. It's a wall.

What does it mean to begin again at 60, 70, or beyond — and what if the door to healing is one most of us were taught to fear?

Join us for the Vancouver premiere of The Next Chapter, a deeply human documentary about psilocybin-assisted therapy and the courage it takes to seek healing in the second half of life. This special screening is followed by a live panel Q&A with filmmaker Scott Paul Wright and a remarkable group of voices at the intersection of mental health, medicine, and lived experience.

About the Film

The Next Chapter follows a group of people navigating the second half of life who refused to accept that their best days were behind them. Carrying the weight of depression, anxiety, grief, and long-unresolved pain, they stepped into the world of psilocybin-assisted therapy in search of something they had nearly stopped believing in: the possibility of healing. This is not a film about a treatment. It is a deeply personal story about courage, vulnerability, and what it means to begin again.

The Evening

🎬 Doors open: 6:00pm
📽️ Screening: 7:00pm (~45 minutes)
🎤 Panel Q&A: immediately following
📍 VIFF Cinema, 1181 Seymour St, Vancouver

Check out the teaser reel here

Meet the Panelists

Scott Paul Wright — Filmmaker, The Next Chapter
Scott Paul Wright is a filmmaker, writer, and producer whose work has consistently explored the human story behind larger subjects. With The Next Chapter, the subject is also personal — Wright came to psilocybin through his own experience at 68, reflecting the life stage of many of the people featured in the film. He joins us live for this Vancouver premiere.

Corey Hirsch — Former NHL Goaltender & Mental Health Advocate
Corey Hirsch is a former NHL goaltender, Olympic silver medalist, and former colour commentator for the Vancouver Canucks with Sportsnet Radio. After his professional hockey career, Corey became one of Canada's most recognized voices in the fight to end stigma around mental health — speaking openly about his own diagnosis and the silence that surrounds mental illness in sport and beyond. His 2017 essay in The Players' Tribune sparked a national conversation and has made him a powerful advocate for open dialogue, vulnerability, and the importance of asking for help.

Treya Klassen — Psychedelic Therapist, Strategist & Advocate
Treya Klassen is the founder of Dehoco, an award-winning brand and strategy firm that has helped shape organizations across the psychedelic sector. A trained psychedelic therapist, she serves on the boards of 343 Fund — which provides funding for psychedelic-assisted therapies for first responders — and Full Potential Communities, supporting research and plant medicine advocacy. She co-created Sacred Medicine, Modern Crime, a documentary highlighting Indigenous ayahuasca traditions and healing, and is dedicated to advancing responsible access to psychedelic-assisted therapies.

Presented by the Psychedelic Association of Canada in partnership with MAPS Canada

*Please note this webinar is 1 hr and will begin at 3:00pm PT/6:00pm ET

Something shifted in Ottawa this week.

On June 16th, Conservative MP Corey Tochor introduced Bill C-286 — Thomas's Law — legislation that would allow Canadian physicians to prescribe psilocybin directly to patients, bypassing the federal approval process that has left thousands of people without access to a treatment that research shows can be life-changing.

The bill bears the name of Thomas Hartle — a Saskatchewan father who, in 2020, became the first Canadian to receive a legal psilocybin exemption while battling stage IV colon cancer. When his cancer progressed, his renewal requests sat unanswered for months. A dying man spent his final years fighting bureaucratic silence just to keep a treatment that was helping him. Thomas passed away in 2024. This bill is his legacy.

Since January 2022, Health Canada has issued only 354 psilocybin authorizations through the Special Access Program — with approval rates now sitting at roughly 30%. For patients living with PTSD, treatment-resistant depression, addiction, and end-of-life distress, that's not a safety net. It's a wall.

Join us for a live conversation with the MP who decided to do something about it.

Dr. Pamela Kryskow — physician, researcher, and PAC Board Chair — sits down with MP Tochor to cover:

• What brought him to this bill — the conversations, the cases, and the moment a Conservative MP decided psilocybin access was worth fighting for
• What Canadians told him — the stories from patients, families, and clinicians that shaped the legislation
• How a private member's bill actually works — a plain-language walkthrough of the parliamentary process, from tabling to committee to vote
• What it needs to pass — the political landscape, the numbers, and what has to happen next
• What you can do right now — concrete ways Canadians can support Bill C-286 and help it move forward

Whatever your background — patient, practitioner, advocate, or curious citizen — this is a conversation that matters. A cross-party moment in Canadian psychedelic medicine policy is rare. This is one.